Table 6 Overall-survival analyses for UBEC2C and Ki-67 adjusted for NPI (parametric and 1000-permutation tests)

From: Validation of UBE2C protein as a prognostic marker in node-positive breast cancer

Variable

HR

HR 95% CI

Parametric P -value

1000-permutation P -value

NPI a

    

 1, 2 vs 3

2.86

1.01–8.07

0.047

0.038

UBE2C IHC

    

 <11% vs 11%

4.52

0.96–21.32

0.057

0.040

NPIb

    

 1, 2 vs 3

3.15

1.14–8.76

0.028

0.029

Ki-67 IHC

    

 <11% vs 11%

4.98

0.61–40.56

0.133

0.074

  1. CI=confidence interval; HR=hazard ratio; IHC=immunohistochemistry; NPI=Nottingham prognostic index.
  2. a NPI adjusted for UBE2C IHC.
  3. b NPI adjusted for Ki-67 IHC.